Myxoid liposarcoma accounts for 30-50% of liposarcomas, and the majority of the cases are characterized by either t(12;16)(q13;p11) translocation, causing the FUS-CHOP product or, more rarely, translocation of t(12;22)(q13;q12), creating the fusion gene EWSR1-CHOP [19,54]. The gene discussed is DDIT3; the disease is myxoid liposarcoma.